Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation × Endocrine × 90 days × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 56 Pheochromocytoma 21 Carcinoma, Neuroendocrine 17 Adrenocortical Carcinoma 17 Thyroid Cancer, Papillary 16 Paraganglioma 16 Pituitary Neoplasms 15 Thyroid Neoplasms 12 Adenoma, Islet Cell 12 Multiple Endocrine Neoplasia Type 1 11 Gastro-enteropancreatic neuroendocrine tumor 11 Breast Neoplasms 11 Neoplasms 10 Brain Neoplasms 10 Prostatic Neoplasms 9 Neoplasm Metastasis 9 Melanoma 8 Colorectal Neoplasms 8 Carcinoma, Hepatocellular 8 Carcinoid Tumor 8 Sarcoma 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Adrenal Gland Neoplasms 7 Pituitary ACTH Hypersecretion 6 Neuroblastoma 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Carcinoma, Anaplastic 5 Stomach Neoplasms 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡